Back to top
Apretero 125 mg -80 mg Capsule
Apretero 125 mg -80 mg Capsule

Apretero 125 mg -80 mg Capsule

Apretero 125 mg -80 mg Capsule Specification

  • Origin of Medicine
  • Synthetic
  • Pacakaging (Quantity Per Box)
  • 1 blister pack containing multiple capsules
  • Salt Composition
  • Aprepitant 125 mg and 80 mg
  • Drug Type
  • Capsule
  • Ingredients
  • Apretero 125 mg and 80 mg
  • Physical Form
  • Capsule
  • Function
  • Recommended For
  • Patients undergoing chemotherapy
  • Dosage
  • 125 mg on day 1 followed by 80 mg daily on days 2 and 3
  • Dosage Guidelines
  • Take orally with water approximately 1 hour before chemotherapy
  • Suitable For
  • Adults
  • Quantity
  • As per prescription (commonly 1 blister pack with multiple capsules)
  • Storage Instructions
  • Store at room temperature away from moisture and direct sunlight
 
 

About Apretero 125 mg -80 mg Capsule



Apretero 125 mg -80 mg Capsule is a medication containing Apretero in the dosage of 125 mg and 80 mg in capsule form. It is prescribed to prevent nausea and vomiting induced by chemotherapy. The dosage involves taking 125 mg on day 1, followed by 80 mg daily on days 2 and 3 before chemotherapy. This synthetic medicine is suitable for adults and comes in blister packs with multiple capsules. Remember to store it at room temperature, away from moisture and sunlight. Apretero 125 mg -80 mg Capsule is recommended for patients undergoing chemotherapy.

FAQs of Apretero 125 mg -80 mg Capsule:


Q: What is the function of Apretero 125 mg -80 mg Capsule?

A: Apretero 125 mg -80 mg Capsule is used to prevent nausea and vomiting caused by chemotherapy.

Q: How should I take Apretero 125 mg -80 mg Capsule?

A: The recommended dosage is 125 mg on day 1 and 80 mg daily on days 2 and 3, to be taken orally with water about an hour before chemotherapy.

Q: Who is Apretero 125 mg -80 mg Capsule suitable for?

A: Apretero 125 mg -80 mg Capsule is suitable for adults undergoing chemotherapy.

Q: What is the composition of Apretero 125 mg -80 mg Capsule?

A: The salt composition of Apretero 125 mg -80 mg Capsule includes Aprepitant 125 mg and 80 mg.

Q: How should I store Apretero 125 mg -80 mg Capsule?

A: It is advisable to store Apretero 125 mg -80 mg Capsule at room temperature, away from moisture and direct sunlight.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Nausea Category

Aprecap Capsule

Aprecap Capsule

Recommended For : Patients undergoing chemotherapy or postsurgical procedures

Storage Instructions : Store in a cool and dry place below 30C away from direct sunlight

Physical Form : Other, Capsule

Ingredients : Aprepitant

Quantity : 10 capsules per strip

Dosage Guidelines : Take orally with or without food; follow doctors instructions

Amitant 150 mg Injection

Amitant 150 mg Injection

Recommended For : Patients undergoing chemotherapy radiation therapy or surgery

Storage Instructions : Store in a cool and dry place protected from light and at a temperature between 2C and 8C

Physical Form : Liquid

Ingredients : Ondansetron

Quantity : 1 vial

Dosage Guidelines : Administer as prescribed by the healthcare professional typically via intravenous or intramuscular injection

Emetant 150 mg Injection

Emetant 150 mg Injection

Recommended For : Patients experiencing nausea and vomiting due to chemotherapy or postsurgical conditions

Storage Instructions : Store below 25C away from light and moisture

Physical Form : Other, Injection

Ingredients : Granisetron Hydrochloride

Quantity : Single injection per vial

Dosage Guidelines : Administer as prescribed by a medical professional; typically intravenously before chemotherapy or surgery

Fosapp 150 mg Injection

Fosapp 150 mg Injection

Recommended For : Patients undergoing chemotherapy

Storage Instructions : Store below 25C and protect from light

Physical Form : Liquid

Ingredients : Fosaprepitant 150 mg

Quantity : 1 vial

Dosage Guidelines : Administered as an injection under the supervision of a healthcare professional